SpringWorks Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
SWTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Washington Boulevard, Stamford, CT

Insiders trading volume in the past year

SpringWorks Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephen P. Squinto Director, 10%+ Owner $262M May 19, 2022
Orbimed Advisors Llc 10%+ Owner $233M Sep 12, 2022
Bain Capital Life Sciences Investors, LLC 10%+ Owner $201M Aug 10, 2021
Jeffrey Schwartz Director $128M May 24, 2023
Saqib Islam Chief Executive Officer, Director $42.5M -$5.97M -12.3% Dec 2, 2024
Daniel Lynch Director $14.6M May 16, 2024
L. Mary Smith Chief Development Officer $9.69M Jan 4, 2024
Badreddin Edris Chief Operating Officer $8.85M -$2.45M -21.7% Dec 3, 2024
James Cassidy Chief Medical Officer $3.08M Aug 30, 2024
Bhavesh Ashar Chief Commercial Officer $2.68M -$381K -12.4% Apr 1, 2024
Francis I. Perier Jr Chief Financial Officer $2.46M Jan 4, 2024
Daniel Pichl Chief People Officer $2.27M -$1.91M -45.8% Feb 16, 2024
Herschel S. Weinstein General Counsel & Secretary $2.17M Jan 4, 2024
Michael F. Burgess Head of Research & Development $2.06M Jul 18, 2022
Michael Nofi Chief Accounting Officer $1.19M Jan 4, 2024
Carlos Alban Director $895K May 16, 2024
Tai-An Lin Chief Scientific Officer $885K Oct 2, 2024
Freda Lewis-Hall Director $698K May 16, 2024
Alan Fuhrman Director $698K May 16, 2024
Martin Mackay Director $384K Jul 29, 2024
Julie Hambleton Director $172K -$186K -51.9% Jun 3, 2024

Recent Insider Transactions by Companies or Individuals for SpringWorks Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.